Hyperfine, Inc.

Hyperfine, Inc. is a health technology and medical device company dedicated to revolutionizing patient care globally through accessible, clinically relevant diagnostic imaging and data solutions. Founded in 2014, the company's mission centers on democratizing access to magnetic resonance imaging (MRI) by making it more affordable and available. Hyperfine's corporate headquarters are located in Guilford, Connecticut.

The company's flagship product is the Swoop® Portable MR Imaging® System, the first FDA-cleared, AI-powered, portable, ultra-low-field magnetic resonance brain imaging system. This innovative device produces high-quality images at a low magnetic field strength, allowing it to be wheeled directly to a patient's bedside, plugged into a standard electrical outlet, and controlled via an iPad. The Swoop system is designed for use in various clinical settings, including critical care units, emergency departments, neurology offices, and remote or rural environments, aiming to provide rapid diagnoses and treatment. Hyperfine also offers support services and the Hyperfine Image Viewer, a cloud-based picture archiving and communication system.

Maria Sainz has served as President and CEO since October 2022. In recent developments, Hyperfine received CE and UKCA Marks for its next-generation Swoop® system and Optive AI™ software in early 2026, paving the way for commercialization across Europe and the UK. The company also introduced the Swoop® system as India's first portable MRI for bedside brain imaging in April 2026. These advancements, alongside FDA clearance of its Optive AI™ software in May 2025 and a new next-generation Swoop® system in June 2025, underscore Hyperfine's commitment to enhancing image quality and expanding its market presence in neurology offices and international markets. Hyperfine reported Q4 2025 revenue of $5.29 million, a 128% year-over-year increase, with full-year 2025 revenue reaching $13.56 million.